ArticlePediatric research2026
Profiling immune cell subsets in pediatric IgA vasculitis and immune thrombocytopenia: insights into disease pathogenesis and clinical correlates.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIgA vasculitis (IgAV) and immune thrombocytopenia (ITP) are common pediatric immune disorders with distinct clinical presentations. Their underlying peripheral immune signatures, particularly in relation to disease severity and etiology,remain incompletely characterized.
methodWe retrospectively analyzed peripheral blood mononuclear cell (PBMC) subsets from 125 children with IgAV and 35 with ITP using high-dimensional flow cytometry. Patients were stratified by disease severity, current glucocorticoid use at sampling, and etiology.
resultsCompared with ITP, IgAV patients exhibited higher proportions of NK cells, classical monocytes, and activated B-cell subsets (CD38
conclusionsIgAV and ITP display markedly different immune profiles, with IgAV featuring polyclonal B-cell activation and granulocyte/NK-cell-mediated vascular inflammation, whereas ITP is associated with monocyte expansion in severe disease. Infection type and early glucocorticoid exposure significantly modulate these immune landscapes, providing a basis for stratified and personalized therapeutic strategies. IMPACT: High-dimensional flow cytometry identifies stratified PBMC profiles in pediatric IgAV and ITP. Severe IgAV features pro-inflammatory Th9/Th17/Th22 polarization, regulatory B-cell depletion, and LDG elevation. Haemophilus influenzae infection is associated with elevated ThGM-CSF cells in IgAV. Severe ITP cases showed increased monocyte proportions and distinct alterations in T-cell and NK-cell subsets. Prior glucocorticoid exposure and infection type synergistically reshape immune subsets, supporting precision immunology approaches.
Identifiers
42634084What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.